CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BARB aims to enhance charged particle therapy for cancer treatment by utilizing high-intensity radioactive ion beams. This innovative approach seeks to improve treatment precision and reduce uncertainties, particularly for small tumors, by integrating real-time imaging with therapy.
Cancer remains one of the main causes of death worldwide.
In 2018, >50% cancer patients in Europe underwent radiotherapy.
While over 80% were treated using high-energy X-rays, the number of patients receiving accelerated protons or heavy ions (charged particle therapy:
CPT) is rapidly growing, with nearly 200,000 patients treated up till now.
Although CPT offers a better depth-dose distribution compared to common X-ray based techniques, range uncertainty and poor image guidance still limit its a…
GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
